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We report a case of mucinous cystic neoplasm of pancreas with sarcomatous stroma metastasizing to the liver. The
tumor occurred in a male patient aged 46 years. Symptoms included persistent epigastric and right upper quadrant
pain. Radiographically, the pancreas contained four large cystic masses located in the neck, body, and tail.
Histologically, the cysts were lined with benign, mucinous epithelium with underlying bland, storiform, ovarian-like
stroma. An undifferentiated focally hyalinized, sarcomatous stroma composed of bland spindle cells showing short
fascicular growth pattern and focal nuclear palisading was associated with the epithelial component in one of the
cysts. These cells showed strong immunoreactivity with vimentin and inhibin (weak), they were negative for CD34,
estrogen receptor, progesterone receptor, androgen, calretinin, S-100, CD117, melan A, chromogranin, and
synaptophysin. A morphologically and immunohistochemically identical metastatic sarcomatous focus was
identified in the liver without any glandular component. This case is unique in its clinically malignant behaviour
and metastatic nature despite its morphologically benign epithelial and stromal components.Background
Mucinous cystic neoplasms (MCNs) represent one of the
major cystic neoplasms of the pancreas. They have distinct
clinicopathological features. They are seen in women in
the fifth or sixth decades of life; only rarely are examples
documented in men. The tumor is usually located in the
tail of the pancreas. Macroscopically, the cysts are
multilocular and they do not communicate with the pan-
creatic ductal system. Histologically, the lining epithelium
consists of tall, columnar cells with abundant apical
mucin, although cuboidal cells that lack obvious mucin
may also be present. The epithelium may be bland in ap-
pearance or might range from mild to severe atypia resem-
bling ovarian counterparts and include mucinous
cystadenomas, borderline mucinous cystic tumors, and
mucinous cystadenocarcinomas. Another distinct histo-
logic feature is the presence of subepithelial hypercellular,
ovarian-like spindle cell stroma, and its presence has be-
come a requirement for the diagnosis of this entity [1,2].
Here we report a case of mucinous cystic neoplasm of the
pancreas with sarcomatous stroma metastasized to liver.* Correspondence: waynedocny@yahoo.com
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A 46-year-old man presented with persistent epigastric and
right upper quadrant pain. Endoscopic ultrasound studies
revealed multiple cysts in the pancreas (Figures 1A,B).
Computed tomography (Figure 1C) of the abdomen
showed a large mass in the neck and body of the pancreas
measuring 6.8 × 5.7 cm in cross-section, consistent with a
cystic mass with internal hemorrhage. In addition, a 1.2 cm
cystic mass in the pancreatic body and three adjacent cystic
masses in the pancreatic tail measuring 2.3, 1.7, and 1.4 cm
were identified. No pancreatic ductal dilatation was seen.
Pathologic findings
A partial pancreatectomy removed four cysts ranging in
size from 1.5 × 1.5 × 0.8 cm to 7.0 × 5.0 × 3.5 cm, lo-
cated in the neck, body, and tail of the pancreas. All the
cysts had a green-tan to red, smooth, glistening lining.
The parenchyma separating the cysts was tan-yellow and
focally indurated (Figure 2A).
Histologically, the cysts were lined with columnar cells
with mucinous laden cytoplasm and basally located,
bland nucleus. Beneath the epithelial lining, a
hypercellular ovarian-like stroma composed of spindle-
shaped cells in a storiform growth pattern was observedLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Figure 1 Endoscopic ultrasonography and computed tomography. A-B) Endoscopic ulrasonography showing cysts in neck, body and tail
of Pancreas. C) Computed tomography of pancreas showing cystic mass with hemorrhage.
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cular growth pattern and focally nuclear palisading was
evident. In these areas, the cells had mild atypia; how-
ever, no increase in mitotic figures was detected. The
focal areas of the stroma were composed of dense, acel-
lular, hyalinized tissue (Figure 2C). A liver segment
resected at the same time revealed a metastatic stromal
lesion composed entirely of spindle-shaped cells identi-
cal to those seen in the pancreas but without theA
C
Figure 2 Pictures of pancreatic cysts, cyst lined by benign mucinous
metastatic foci in liver. (A) Gross picture of pancreatic cysts occupying ne
underlying ovarian-like, storiform stroma (H & E, 10×) (C) Sarcomatous strom
and nuclear palisading. Focal areas of dense, acellular, hyalinized tissue are
Morphology is identical to lesion in pancreas (H & E, 20×).glandular component (Figure 2D). The uninvolved pan-
creas showed fibrosis and atrophy. All of the 11 lymph
nodes were free of metastasis.
Immunohistochemistry
The epithelial component of the cysts was positive for
CAM 5.2 antibody (Figure 3A). The stromal component in
both pancreas and liver was strongly positive for vimentin
(Figure 3B) and weakly positive for inhibin (Figure 3C).B
D
epithelium, sarcomatous stroma in pancreas, and sarcomatoid
ck, body and tail. (B) Cyst lined by benign mucinous epithelium with
a in pancreas. Spindle stromal cells with fascicular growth pattern
evident (H & E, 20×) (D) Sarcomatoid metastatic foci in liver.
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Figure 3 Immunohistochemical studies. (A) Epithelial component of the lesion is CAM5.2 positive. Sarcomatous stroma shows strong vimentin
(B) and weak inhibin (C) immunoreactivity. (D) Sarcomatous component has a low Ki67 index (1% to 3%).
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receptor, progesterone receptor, androgen, calretinin, S-100,
CD117, melan A, chromogranin, and synaptophysin. The
Ki67 index of stroma was low, 1% to 3% (Figure 3D).
Discussion
Sarcomatous neoplastic lesions arising from the stroma of
MCNs of the pancreas have been described in the litera-
ture (Table 1). The stromal component may be composed
of bland, spindle cells with mild atypia and a small num-
ber of mitotic figures. These types of lesion have been de-
scribed as ‘mucinous cyst adenoma with mesenchymal
overgrowth or mural nodules’ [3,4]. In these tumors, the
sarcoma-like foci are benign and do not affect the progno-
sis adversely. Other reported examples of MCNs include
an associated malignant spindle cell stroma with charac-
teristic features of malignant fibrous histiosarcoma [5,6],
leiomyosarcoma [7], and undifferentiated pleomorphic
high-grade sarcoma [8-10]. In some of these cases, the epi-
thelial component was also malignant, so a diagnosis of
carcinosarcoma was made.
In three cases reported by Wenig et al. [11,12], stromal
cells showed moderate to high-grade atypia, pleomorph-
ism and increased numbers of mitotic figures. The sar-
comatous component was angioinvasive. Two patients
had metastatic lesions composed of sarcomatous lesion
only. The epithelial component of one of these lesions
showed features of invasive adenocarcinoma.
Our case differs from the previously reported literature
by distant metastasis of only the stromal component,despite its morphologically benign features with bland
spindle cells showing mild atypia, a low number of mi-
totic counts and a low Ki67 index. Both the sarcomatous
stroma in the pancreas and the metastatic foci in the
liver were strongly positive for vimentin and variably
positive for inhibin. Estrogen receptor and progesterone
receptor expression was not detected; this is not unlikely
in MCN of pancreas arising in men.
Conclusion
To the best of our knowledge, this is the first clinically
MCN of the pancreas reported with distant metastasis of
sarcomatous stromal component despite the relatively
benign histologic features of the lesion. Although both
epithelial and stromal components of the lesion are mor-
phologically benign, the presence of a metastatic stromal
focus in the liver renews the discussion that all pancre-
atic MCNs should be regarded as potentially malignant
and that histology alone is not a definitive prospective
indicator of behaviour [11,13]. According to most of the
reported literature, the MCN with sarcomatous tumor
behaves more aggressively; therefore, it is most likely
that the sarcomatous component appears to be respon-
sible for the malignant behaviour of these tumors and
supersedes the epithelial component in terms of defining
the aggressiveness of these tumors.
Consent
The patient has given his consent for this case report to
be published.
Table 1 Summary of reported cases of mucinous cystic neoplasm of pancreas with sarcomatous component
Reference Demographic features Epithelial component Sarcomatous component
Age Sex Histology Histology Immunohistochemistry findings
[8] 48 M MCN, carcinosarcoma Pleomorphism, high-grade atypia, atypical mitosis, necrosis Vimentin (+)
ER, PR (−)
Liver and lymph node metastasis of carcinoma S100 (−)
CD34 (−)
SMA (−)
[9] 70 F MCN, invasive adenocarcinoma Spindle cell sarcoma Vimentin (+)
Mucin 1 (+)
[10] 67 F MCN, invasive adenocarcinoma Pleomorphic sarcoma Vimentin (+)
Moderate to high-grade atypia S100 (−)
Atypical mitosis c-Kit (−)
Metastasis to liver
[3] 30 F MCN MCN with mesenchymal overgrowth ER, PR (+)
Mild atypia, low number of mitoses
No metastasis
[11] 48 F MCN with atypia MCN with sarcomatous stroma Vimentin, MSA, SMA
ER and PR (+)
66 F MCN with atypia MCN with sarcomatous stroma Vimentin,
Moderate to high-grade atypia MSA, SMA,
Numerous mitoses S100 (variable),
Distant metastasis ER and PR (+)
67 M MCN, invasive adenocarcinoma MCN with sarcomatous stroma Vimentin,
MSA, SMA,
Moderate to high-grade atypia S100 (+)
ER and PR (−)Numerous mitoses
Omental metastasis
[5] 43 F MCN MFH Vimentin, lysozyme, α1 antitrypsin
[4] 45 F MCN Pseudosarcomatous, mural nodules CK, EMA, Vimentin
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H & E: Hematoxylin and eosin; MCN: Mucinous cystic neoplasm;
MFH: Malignant fibrous histiocytoma.
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